Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | LAP3 | P28838 | 3/20 | 0.49 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ACP3 | P15309 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.47 |
| ▸ | ECE1 | P42892 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9245828 | 0.84 | MME (0.52) | MMEL3MBTL1LAP3ANPEPNPSR1 | |
| SCHEMBL3506385 | 0.83 | MME (0.58) | MMEL3MBTL1NPSR1NAALAD2CYP1A2 | |
| SCHEMBL3506387 | 0.83 | MME (0.58) | MMEL3MBTL1NPSR1NAALAD2CYP1A2 | |
| SCHEMBL9242144 | 0.83 | ECE1 (0.64) | MMEL3MBTL1LAP3ANPEPECE1 | |
| SCHEMBL9715666 | 0.83 | MME (0.51) | MMEL3MBTL1LAP3ANPEPNPSR1 | |
| SCHEMBL9068541 | 0.82 | MME (0.70) | MMEL3MBTL1NPSR1NAALAD2CYP1A2 | |
| SCHEMBL7379335 | 0.82 | MME (0.70) | MMEL3MBTL1NPSR1NAALAD2CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL2415760 | 0.81 | MME (0.50) | MMEL3MBTL1LAP3ANPEPNPSR1 | |
| SCHEMBL6770152 | 0.80 | MME (0.55) | MMEL3MBTL1NPSR1NAALAD2CYP1A2 | |
| SCHEMBL3090103 | 0.79 | MME (0.48) | MMEL3MBTL1LAP3ANPEPNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994008600-A1 | INHIBITION OF SIGNAL TRANSDUCTION MOLECULES | JOSLIN DIABETES CENTER (US) | 1994-04-28 | — | — | WO | claimed |
| US-20180264080-A1 | TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION | KINETA ONE, LLC (US) | 2018-09-20 | — | — | US | disclosed |
| US-9937230-B2 | Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof | KINETA ONE, LLC (US) | 2018-04-10 | — | — | US | disclosed |
| US-20160338967-A1 | SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF | KINETA ONE, LLC (US) | 2016-11-24 | — | — | US | disclosed |
| EP-3086779-A2 | SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF | Kineta One, LLC (US) | 2016-11-02 | — | — | EP | disclosed |
| WO-2016112208-A2 | TOPICAL APPLICATIONS OF KV1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION | KINETA ONE, LLP (US) | 2016-07-14 | — | — | WO | disclosed |
| US-20160151457-A1 | OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF | KINETA ONE, LLC (US) | 2016-06-02 | — | — | US | disclosed |
| EP-3024472-A2 | OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Kineta One, LLC (US) | 2016-06-01 | — | — | EP | disclosed |
| WO-2015100370-A2 | SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF | KINETA ONE, LLC (US) | 2015-07-02 | — | — | WO | disclosed |
| WO-2015013330-A2 | OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF | KINETA ONE, LLC (US) | 2015-01-29 | — | — | WO | disclosed |
| US-5801149-A | PEPTIDS FOR INHIBITION OF PROTEINS | JOSLIN D-ABETES CENTER, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| US-5475129-A | Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-12-12 | — | — | US | disclosed |
| WO-1994008600-A1 | INHIBITION OF SIGNAL TRANSDUCTION MOLECULES | JOSLIN DIABETES CENTER (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1993025561-A1 | PHOSPHONOALKYL PHENYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-12-23 | — | — | WO | disclosed |
| US-5264607-A | Process of making benzylic α,α-diflurophosphonates from benzylic α-ketophosphorates | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-11-23 | — | — | US | disclosed |